DEFA4 and inflammatory bowel disease: Furthermore, DEFA4 exhibits pro-inflammatory activity in the intestine by activating macrophages and amplifying local inflammatory responses, leading to intestinal permeability and systemic inflammation [59], which plays a role in autoimmune diseases such as inflammatory bowel disease.